Tomuschat C, Puri P
National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland.
Pediatr Surg Int. 2015 Aug;31(8):701-10. doi: 10.1007/s00383-015-3731-y. Epub 2015 Jul 12.
During the past two decades several genes have been identified that control morphogenesis and differentiation of the enteric neuron system (ENS). These genes, when mutated or deleted, interfere with ENS development. RET gene is the major gene causing Hirschsprung's disease (HD). Mutations in RET gene are responsible for 50% of familial HD cases and 15-20% of sporadic cases. The aim of this meta-analysis was to determine the incidence of RET gene mutations in patients with HD and to correlate RET mutations with the extent of aganglionosis.
A systematic literature-based search for relevant cohorts was performed using the terms "Hirschsprung's disease AND RET Proto-oncogene", "Hirschsprung's disease AND genetic polymorphism" and "RET Gene". The relevant cohorts of HD were systematically searched for reported mutations in the RET gene (RET+). Data on mutation site, phenotype, and familial or sporadic cases were extracted. Combined odds ratio (OR) with 95% CI was calculated to estimate the strength of the different associations.
In total, 23 studies concerning RET with 1270 individuals affected with HD were included in this study. 228 (18%) of these HDs were RET+. Of these 228, 96 (42%) presented as rectosigmoid, 81 (36%) long segment, 18 (8%) as TCA, 16 (7%) as total intestinal aganglionosis and 17 (7%) individuals were RET+ but no extent of aganglionosis was not reported. In the rectosigmoid group, no significant association between phenotype and RET mutation could be shown (P = 0.006), whereas a clear association could be shown between long-segment disease, total colonic- and total intestinal aganglionosis and RET mutations (P = 0.0002). Mutations most often occurred in Exon 13 (24) and showed significant association with rectosigmoid disease (P = 0.004). No significance could be shown between RET+ and sporadic cases (P = 0.53), albeit a trend towards RET+ and Familial cases could be observed (P = 0.38).
The association with the RET gene and HD is well recognized. This study showed a clear association between RET+ mutations and the long-segment, total colonic- and total intestinal aganglionosis. Exon 13 appears to be a mutational "hot spot" in rectosigmoid disease.
在过去二十年中,已鉴定出几种控制肠神经系统(ENS)形态发生和分化的基因。这些基因发生突变或缺失时,会干扰ENS的发育。RET基因是导致先天性巨结肠症(HD)的主要基因。RET基因突变占家族性HD病例的50%,散发性病例的15 - 20%。本荟萃分析的目的是确定HD患者中RET基因突变的发生率,并将RET突变与无神经节细胞症的范围相关联。
使用术语“先天性巨结肠症 AND RET原癌基因”、“先天性巨结肠症 AND 基因多态性”和“RET基因”,基于文献对相关队列进行系统检索。对HD的相关队列系统检索报道的RET基因(RET+)突变。提取关于突变位点、表型以及家族性或散发性病例的数据。计算合并比值比(OR)及95%置信区间(CI),以估计不同关联的强度。
本研究共纳入23项关于RET的研究,涉及1270例HD患者。其中228例(18%)为RET+。在这228例中,96例(42%)表现为直肠乙状结肠型,81例(36%)为长段型,18例(8%)为全结肠无神经节细胞症(TCA),16例(7%)为全肠无神经节细胞症,17例(7%)为RET+但未报告无神经节细胞症的范围。在直肠乙状结肠组中,未显示表型与RET突变之间存在显著关联(P = 0.006),而长段型疾病、全结肠和全肠无神经节细胞症与RET突变之间显示出明显关联(P = 0.0002)。突变最常发生在外显子13(24例),并与直肠乙状结肠疾病显示出显著关联(P = 0.004)。RET+与散发性病例之间未显示出显著性(P = 0.53),尽管可观察到RET+与家族性病例之间有一定趋势(P = 0.38)。
RET基因与HD的关联已得到充分认识。本研究显示RET+突变与长段型、全结肠和全肠无神经节细胞症之间存在明显关联。外显子13似乎是直肠乙状结肠疾病的突变“热点”。